Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of careHAWKINS, David.American journal of health-system pharmacy. 2003, Vol 60, issn 1079-2082, 24 p., SUP7Conference Proceedings

Venous thromboembolism: Pathophysiology and clinicat présentationHAINES, Stuart T.American journal of health-system pharmacy. 2003, Vol 60, pp 3-5, issn 1079-2082, 3 p., SUP7Conference Paper

Pharmacoeconomic considerationsLOBO, Bob L.American journal of health-system pharmacy. 2003, Vol 60, pp 11-14, issn 1079-2082, 4 p., SUP7Conference Paper

Clinical trials with factor Xa inhibition in the prevention of postoperative venous thromboembolismHAWKINS, David.American journal of health-system pharmacy. 2003, Vol 60, pp 6-10, issn 1079-2082, 5 p., SUP7Conference Paper

Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disordersTURPIE, Alexander G. G.American journal of health-system pharmacy. 2003, Vol 60, pp 20-24, issn 1079-2082, 5 p., SUP7Conference Paper

Novel concepts: Emerging data and the role of extended prophylaxis following hip fracture surgeryDOBESH, Paul P.American journal of health-system pharmacy. 2003, Vol 60, pp 15-19, issn 1079-2082, 5 p., SUP7Conference Paper